Genetic analysis of CAV1 gene in hypertension and metabolic syndrome

Thrombosis and Haemostasis

Volumn 95, Issue 4, 2006, Pages 696-701

  Grilo, Antonio ^a   Fernandez, Maria Luisa ^a   Beltrán, Manuel ^a   Ramirez Lorca, Reposo ^b   González, María Angeles ^a   Royo, Jose Luis ^b   Gutierrez Tous, Reyes ^a   Morón, Francisco Jesús ^b   Couto, Carmen ^a   Serrano Rios, Manuel ^c   Saez, Maria Eugenia ^b   Ruiz, Agustin ^b   Real, Luis Miguel ^b  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

CAV1; Genetics; Hypertension; Metabolic syndrome; NOS3

Indexed keywords

CAVEOLIN 1; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE CLUSTER; GENE INTERACTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; THROMBOGENESIS;

CASE-CONTROL STUDIES; CAVEOLIN 1; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; MODELS, GENETIC; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; SEQUENCE ANALYSIS, DNA; THROMBOSIS;

EID: 33645742547     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-10-0699     Document Type: Article

References (32)

1. Freeman MS, et al. Insulin resistance: an atherothrombotic syndrome. The Leeds family study Thromb Haemost 2003; 89: 161-8.
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
3. Ford ES, et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
4. Meigs JB. Epidemiology of the metabolic syndrome. Am J Manag Care 2002; 8: S283-92.
5. Fernandez ML, et al. Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb Haemost 2004; 92: 413-8.
6. Nakayama M, et al. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-70.
7. Duplain H, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001; 104: 342-5.
8. Feron O, et al. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996; 271: 22810-4.
9. Blair A, et al. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs cNOS activation. J Biol Chem 1999; 274: 32512-9.
10. Feron O, et al. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 1999; 103: 897-905.
11. Garcia-Cardena G, et al. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 1996; 27: 27237-40.
12. Garcia-Cardena G, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 1997; 272: 25437-40.
13. Couet J, et al. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997; 272: 6525-33.
14. Li S, et al. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 1996; 271: 29182-90.
15. Lisanti MP, et al. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 1994; 4: 231-5.
16. Oh P, et al. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 1998; 141: 101-14.
17. Henley JR, et al. Dynamin-mediated internalization of caveolae. J Cell Biol. 1998; 141: 85-99.
18. Babitt J, et al. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997; 272: 13242-9.
19. Fielding CJ, Fielding PE. Caveolae and intracellular trafficking of cholesterol. Adv Drug Deliv Rev 2001; 49: 251-64.
20. Cohen AW, et al. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004; 53: 1261-70.
21. Williams TM, Lisanti MP. The Caveolin genes: from cell biology to medicine. Ann Med 2004; 36: 584-95.
22. Razani B, et al. Caveolin-1 -deficient mice are lean, resistant to diet-induced obesity, and show hypertrigly ceridemia with adipocyte abnormalities. J Biol Chem 2002; 277: 8635-47.
23. Cohen AW, et al. Caveolin-1 -deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 2003; 285: C222-35.
24. Razani B, et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001; 276: 38121-38.
25. Meigs JB. Epidemiology of cardiovascular complications in type 2 diabetes mellitus. Acta Diabetol 2003; 40 (Suppl 2): S358-61.
26. Real LM, t al. Detection of nucleotide c985 A-->G mutation of medium-chain acyl-CoA dehydrogenase gene by real-time PCR. Clin Chem 2001; 47: 958-9.
27. Sasieni PD. From genotypes to genes: Doubling the sample size. Biometrics 1997; 53: 1253-61.
28. Sampson LJ, et al. Caveolae localize protein kinase A signaling to arterial ATP-sensitive potassium channels. Circ Res 2004; 95: 1012-8.
29. Ishizaka N, et al. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 1998; 32: 459-66.
30. Cohen AW, et al. Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 2003; 285: E1151-60.
31. Nystrom FH, et al. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocrinol 1999; 13: 2013-24.
32. Razani B, et al. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. J Biol Chem 1999; 274: 26353-60.